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Background: Although there are several case reports of human parvovirus B19 infection in patients with hereditary
spherocytosis, no systematic reviews of adult patients with hereditary spherocytosis with human parvovirus B19
infection have been published as clinical case reports. In this study, we report a case of aplastic crisis due to human
parvovirus B19 infection in an adult patient with hereditary spherocytosis.
Case presentation: A 33-year-old woman with hereditary spherocytosis and gallstones was admitted because of rapid
progress in marked anemia and fever. Although empiric antibiotic therapy was prescribed, her clinical symptoms and
liver function test worsened. Because the anti-human parvovirus B19 antibody and deoxyribonucleic acid levels
assessed by polymerase chain reaction were positive, the patient was diagnosed with aplastic crisis due to the human
parvovirus B19 infection.
Conclusion: We collected and reviewed several case reports of patients with hereditary spherocytosis aged > 18 years
with human parvovirus B19 infection between 1984 and 2010. A total of 19 reports with 22 cases [median age, 28 years
(range, 18–43 range); male: female ratio, 6:16], including the present case were identified. The male-to-female ratio of
6:16 implied that younger females were predominantly affected. Although fever and abdominal symptoms were
common initial symptoms, liver dysfunction or skin eruptions were less commonly documented. Anti-human parvovirus
B19 antibody or deoxyribonucleic acid levels assessed by polymerase chain reaction was commonly used to diagnose
human parvovirus B19 infection and may be useful to distinguish human parvovirus B19 infection from other
abdominal infection in patients with hereditary spherocytosis.
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Human parvovirus (HPV)-B19 infection can cause aplastic
crisis in a patient with hereditary spherocytosis (HS) asso-
ciated with chronic hemolysis [1]. Although there are sev-
eral case reports of HPV-B19 infection in patients with
HS, particularly in children, no reports have reviewed this
infection in a series of adult patients. In this study, we re-
port a case of HPV-B19 infection-induced aplastic crisis in
an adult patient. In addition to this case, we reviewed sev-
eral adult patients with HPV-B19 infection and HS.* Correspondence: eumagene@gmail.com
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A 33-year-old woman was transferred to our hospital be-
cause of fever, general fatigue, nausea, and progressive
anemia. The patient’s condition was normal until 1 week
before admission, when she experienced flu-like symp-
toms such as fever, general fatigue, and abdominal dis-
comfort. The patient was diagnosed with HS at the age
of 6 in another hospital by the presence of hemolytic
anemia, spherocytosis, increased fragility of spherocytes
by osmotic fragility testing, and the absence of anti-
bodies by direct or indirect Coombs test. Asymptomatic
gallstones were diagnosed at the age of 19. The patient
had undergone her annual blood test examination, and
her hemoglobin concentration was maintained at ap-
proximately 10–12 g/dl. The patient was not under rou-
tine medications. Neither her parents nor her siblingsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Clinical course of the patient. Abbreviations; RCC- Red Cell
Concentrates, HPV-human parvovirus, Hb- hemoglobin, Ret- reticulocyte,
Plt- platelet.
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http://www.biomedcentral.com/1756-0500/7/137had a history of HS. On admission, vital signs were as
follows: blood pressure, 108/56 mmHg; pulse rate, 100
beats/min; body temperature, 39.0°C; and respiration
rate, 12 breaths/min. While breathing ambient air, the
patient’s oxygen saturation rate was 100%. On examin-
ation, she was alert, the skin and conjunctivae were
pale, and the enlarged spleen was palpable from the cos-
tal margin. No skin rash or lymphadenopathy was ob-
served; other physical findings were normal. The results
of laboratory tests were as follows: white blood cell count
was 2.97 × 109/l (granulocytes, 35%; lymphocytes, 44%;
atypical lymphocytes, 9%; and monocytes, 12%), red blood
cell count was 1.68 × 1012/l; hemoglobin concentration was
5.4 g/dl; hematocrit was 14.4%; mean corpuscular volume
was 86 fl; mean corpuscular hemoglobin was 32.1 pg; mean
corpuscular hemoglobin concentration was 37.5%; and
platelet count was 84 × 109/l. Reticulocytes decreased to
0%. Spherocytosis was present on the peripheral blood
smear. Liver function tests revealed levels of aspartate
transaminase (AST) of 39 IU/l, alanine aminotransferase
(ALT) of 31 IU/l, lactate dehydrogenase (LDH) of 342 IU/l,
alkaline phosphatase (ALP) of 144 IU/l, γ-glutamyl trans-
peptidase (γ-GT) of 23 IU/l, total bilirubin of 2.9 mg/dl,
and direct bilirubin of 1.0 mg/dl. Hepatitis B virus surface
antigen and anti-hepatitis C virus antibody were negative.
Haptoglobin concentration decreased to 2 mg/dl, and the
direct antiglobulin test was negative. Phosphatidylinositol
glycan deficient clone was ruled out by flow cytometry. In
addition to the past history, the presence of spherocytes on
the peripheral blood smear, and the presence of gallstones,
the definite diagnosis of HS was made with lower fluores-
cence of eosin-5-maleimide (EMA)-stained red blood cells
due to the decreased amount of target proteins by a flow
cytometry-based test (EMA binding test) [2] and shortened
the acidified glycerol lysis test (AGLT) value [3] after ad-
mission. Because of high fever, history of gallstones, and
the presence of pancytopenia, empiric administration of
antibiotics was initiated for possible abdominal infection.
The patient received two units of packed red blood cell
and showed marked clinical improvement. On the 7th hos-
pital day, fever relapsed and gastrointestinal symptoms (ab-
dominal discomfort and nausea) worsened. Liver function
tests showed levels of AST as 492 IU/l, ALT as 320 IU/l,
LDH as 517 IU/l, ALP as 351 IU/l, γ-GT as 166 IU/l, total
bilirubin as 2.1 mg/dl, and direct bilirubin as 1.0 mg/dl.
Computed tomography of the abdomen showed spleno-
megaly and gallstones, without hepatobiliary tract infec-
tion. Magnetic resonance cholangiography revealed no
evidence of choledocholithiasis; blood cultures were nega-
tive. The results of anti-HPV immunoglobulin M (IgM)
and immunoglobulin G (IgG) measured at admission were
both positive, and HPV-B19 deoxyribonucleic acid (DNA)
increased to 105 copy/ml by quantitative real-time poly-
merase chain reaction (PCR) using the patient’s peripheralblood. Thus, HPV-B19-induced aplastic crisis was diag-
nosed. Because of rapid recovery of hematopoiesis and
clear evidence of HPV infection, bone marrow aspir-
ation was not performed during admission. Liver func-
tion tests returned to normal without treatment. On the
14th hospital day, the patient was discharged without
any symptoms, and the hemoglobin concentration ele-
vated to 8.9 g/dl (Figure 1).
We systematically reviewed the case reports of HPV-
B19 infection that occurred in adult patients with HS and
conducted a literature search using the “Pubmed” search
engine. The following terms “hereditary spherocytosis”
and “parvovirus B19” were used to identify the appropriate
peer-reviewed, English-language papers. We collected
cases of adults, defined as patients over 18 years of age,
and excluded pediatric cases. In addition to the present
case, we reviewed all these cases, collected clinical infor-
mation described in these articles, if written, and discussed
the outcome. Between 1984 and 2010, a total of 19 reports
with 22 cases, including the present case were identified
[4-21]. Patients’ characteristics, including those of the
present case, are summarized in Table 1. Family history of
HS was detected in 13 cases. Fever and liver dysfunction
was documented in 18 and 4 cases, respectively. Skin
manifestation was documented in only 2 cases. HPV-B19
infection was diagnosed through detection of anti-HPV
B19 antibody in 12 cases, HPV-B19 DNA using PCR in 1
case, both antibody and PCR in 7 cases, and others in 2
cases.
Discussion
In this study, we presented a case of HPV-B19-induced
aplastic crisis in an adult patient with HS, and we per-
formed a review of clinical features of previously published
cases. The results of our review showed that all patients
were young, aged 18–43 years. Retrospective studies of
immunocompetent subjects infected with parvovirus B19
showed that affected patients were relatively young; in one
Table 1 Clinical characteristics of 22 cases with human parvovirus B19 (HPV-B19) infection in adult patients with hereditary spherocytosis
Reference Age Gender Initial symptom Family history
of HS






[4] 33 Female Fever, abdominal pain, swelling of the hands,
fatigue, headache, palpitations, dizziness
Yes Yes Yes - - - Antibody
[4] 28 Male Lethargy, weakness, shivering, muscular pain,
headache, palpitation, dizziness
Yes - Yes - - - Antibody
[5] 27 Male Fever, night sweat, shivers, stiffness, headache,
dry cough, dizziness
Yes Yes Yes - - - Antibody
[6] 27 Male Fever, headache, pain, sweating, cough Yes Yes Yes - - - Antibody
[6] 37 Female Fever, headache, sore throat, pains, cough - Yes Yes - - - Antibody
[7] 30 Female - - - - - - - Antibody
[8] 43 Female Fever, headache, nausea, diarrhea Yes Yes - - - - Antibody
[9] 34 Female Fever, malaise, fatigue, palpitation, arthralgia,
headache, dizziness
Yes Yes Yes Yes Yes - Antibody
[10] 34 Female Fever, jaundice, anemia Yes Yes Yes - - - Immunoelectrophoresis
[11] 18 Male Vomiting, fever, lethargy Yes Yes - - - - Antibody in situ
hybridization
[12] 23 Female Low back pain, arthralgia, fever, nausea, vomiting,
diffuse abdominal pain
Yes Yes Yes - Yes Yes Antibody
[13] 36 Female Fever, myalgia, malaise - Yes Yes - - - Antibody, PCR
[14] 19 Male Malaise, anorexia, night sweats - Yes Yes - - - Antibody, PCR
[15] 27 Female Arthralgia, pharyngitis, cough, nausea, vomiting, diarrhea Yes - Yes - - - PCR
[16] 22 Female Anemia, jaundice - - Yes - - - Antibody
[17] 28 Male Leg pain, fatigue - Yes - - - Yes Antibody
[18] 19 Female Fever, malaise, urinary frequency Yes Yes Yes - - Yes Antibody, PCR
[18] 27 Female Fever, malaise, splenomegaly Yes Yes Yes - - - Antibody, PCR
[19] 19 Female Nausea, vomiting, dyspnea, sever fatigue, anemia Yes Yes - Yes - Yes Antibody, PCR
[20] 34 Female Presyncope, fever, myalgia - Yes Yes - - - Antibody, PCR
[21] 34 Female Anemia, fever - Yes Yes Yes - Yes Antibody
Present case 33 Female Fever, fatigue, nausea, anemia - Yes Yes Yes - Yes Antibody, PCR
A hyphen shows that there is no evidence or no description of each characteristic on the article.
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aged 26–45 years [22], while in another report [23], the
median age was 32–43 years (average, 38.0 years) for
males and 15–43 years (average, 34.2 years) for females.
Most individuals are infected with HPV-B19 during their
school years, and the percentage of those with measurable
levels of B19-specific IgG increases with age. More than
70% adults have measurable levels of B19-specific IgG
antibodies [24,25]. Permanent immunity from HPV may
decrease the incidence of viral infection in older patients
with HS.
These cases were more frequently reported in females
than in males. In the epidemiologic study of HPV-B19
infection-induced aplastic crisis in 308 children with
homozygous sickle cell disease, the number of infected pa-
tients did not differ between genders [26]. The analysis of
HPV-B19-induced epidemic acute red cell aplasia in 26
patients, primarily in children with hereditary hemolytic
anemia (including only 1 patient with HS), included 14
males and 12 females [27]. In contrast, in a retrospective
study of 30 immunocompetent patients infected with
parvovirus B19 in Kyoto, the male:female ratio was 4:26
(86.7% were female) [22]. Another retrospective study of
21 healthy, adult patients with HPV-B19 infection in-
cluded 4 males and 17 females [23]. In humans, the gen-
etic background probably accounts for the different
patterns of HPV-induced anemia, and host genes may
regulate the outcome of HPV-B19-induced aplastic crisis
[28]. One may speculate that a correlation exists between
genetic differences and gender gap in association with sus-
ceptibility to HPV infection, although very little is known
with regard to this field.
Fever, nonspecific flu-like symptoms [1], and abdom-
inal symptoms such as nausea or vomiting, abdominal
pain, and diarrhea may occur in patients with HPV-
B19-induced aplastic crisis [27]. Abdominal symptoms
were also commonly observed in our review. In con-
trast, abnormal liver function test results during HPV-
B19 infection was documented in limited cases. In
pediatric patients, elevated levels of hepatic aminotrans-
ferases may accompany the fifth disease, and parvovirus
infection has been associated with severe but self-
limited hepatitis [29]. However, parvovirus B19 could
not be implicated in a large number of adult patients
with acute or chronic hepatitis [1]. The precise incidence
of liver enzyme dysfunction that occurs during HPV-B19
infection in adult patients with HS is uncertain; therefore,
further investigation is required. In a clinical scenario, be-
cause the development of bilirubin gallstones is a common
complication of HS with chronic hemolysis, HPV infection
should be considered as a part of the differential diagnosis
of hepatobiliary tract infection in patients with HS since
fever, abdominal pain, and liver enzyme dysfunction will
also occur with such infection.Documentation of skin manifestation was less frequent
and may be considered to have less diagnostic value for
HPV infection in adults. Similar to the fifth disease [1], al-
though the skin rash is a well-known symptom, it is less
characteristic in adults. In the report including 22 children
with sickle cell disease or HS, no skin rash was observed
during parvovirus B19-induced aplastic crisis [30]. The
pathogenesis of the HPV-B19 infection-induced rash re-
mains unclear. Because it usually coincides with the pro-
duction of measurable serum antibody, it is presumed to
be at least partially immune mediated [31-33]. Different
immune reactions according to age may be associated
with the varying incidences of skin reaction; however, the
precise reason remains unclear.
HPV-B19 infects erythroid progenitor cells and inhibits
erythropoiesis, leading to acute erythroblastopenia and
reticulocytopenia [34]. The bone marrow in patients with
transient aplastic crisis is characterized by an absence of
maturing erythroid precursors and presence of giant pro-
normoblasts [1]. Although giant pronormoblasts are sug-
gestive of parvovirus B19 infection, they are not diagnostic
of the disease [21,24]. Because of pancytopenia accompan-
ied with a marked decrease in reticulocytes as well as a
history of HS, it was natural to believe that the patient in
the present case was suffering from aplastic crisis due to
viral infection; therefore, we did not perform bone marrow
aspiration. Bone marrow aspiration may not be routinely
required when viral infection-induced aplastic crisis is
highly suspected.Conclusion
We report a case of aplastic crisis caused by HPV-B19
in an adult patient with HS. To the best of our know-
ledge, the current study is the first report that reviewed
HPV-B19-induced aplastic crisis in several adult pa-
tients with HS. HPV-B19 infection-induced aplastic
crisis is more common in young female patients with
HS. Although fever or abdominal symptoms generally
occur during HPV-B19 infection, skin manifestation
may appear less commonly. It may be helpful to detect
HPV-B19 infection by antibody or PCR methods to
distinguish it from other infections, such as hepatobili-
ary infection due to gallstones, if suspected.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
ages. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.Competing interests
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